Moving targets: cell migration inhibitors as new anti-inflammatory therapies.
about
Gq-Coupled Receptors in AutoimmunityRole of G protein-coupled receptors in control of dendritic cell migrationTreatment of allergic asthma: modulation of Th2 cells and their responsesThe early activation marker CD69 regulates the expression of chemokines and CD4 T cell accumulation in intestineStructural studies of an anti-inflammatory lectin from Canavalia boliviana seeds in complex with dimannosidesA High-Throughput, Multi-Cell Phenotype Assay for the Identification of Novel Inhibitors of Chemotaxis/Migration.Three-dimensional migration of macrophages requires Hck for podosome organization and extracellular matrix proteolysisInflammatory cell recruitment in cardiovascular disease: murine models and potential clinical applicationsExpression of CCL20 and Its Corresponding Receptor CCR6 Is Enhanced in Active Inflammatory Bowel Disease, and TLR3 Mediates CCL20 Expression in Colonic Epithelial CellsInflammation-a Critical Appreciation of the Role of Myeloid CellsThe F-BAR protein PSTPIP1 controls extracellular matrix degradation and filopodia formation in macrophages.MEKK2 regulates paxillin ubiquitylation and localization in MDA-MB 231 breast cancer cells.Convolution of chemoattractant secretion rate, source density, and receptor desensitization direct diverse migration patterns in leukocytesLeukocyte Trafficking in Cardiovascular Disease: Insights from Experimental ModelsStepwise inhibition of T cell recruitment at post-capillary venules by orally active desulfated heparins in inflammatory arthritisChemical Profile and Antioxidant, Anti-Inflammatory, Antimutagenic and Antimicrobial Activities of Geopropolis from the Stingless Bee Melipona orbignyiThe cyclophilin-binding agent Sanglifehrin A is a dendritic cell chemokine and migration inhibitorEnhanced tumor cell isolation by a biomimetic combination of E-selectin and anti-EpCAM: implications for the effective separation of circulating tumor cells (CTCs)Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis.Ninjurin1 enhances the basal motility and transendothelial migration of immune cells by inducing protrusive membrane dynamics.CXCR3⁺CCR5⁺ T cells and autoimmune diseases: guilty as charged?Effects of inflammatory cytokine IL-27 on the activation of fibroblast-like synoviocytes in rheumatoid arthritisCombinative in vitro studies and computational model to predict 3D cell migration response to drug insultThe chemokine receptor CXCR2 ligand KC (CXCL1) mediates neutrophil recruitment and is critical for development of experimental Lyme arthritis and carditis.A real time chemotaxis assay unveils unique migratory profiles amongst different primary murine macrophages.Direct measurements on CD24-mediated rolling of human breast cancer MCF-7 cells on E-selectin.Targeting Rho-GTPases in immune cell migration and inflammation.Image-based analysis of primary human neutrophil chemotaxis in an automated direct-viewing assay.Targeting tumor cell motility to prevent metastasis.Role and species-specific expression of colon T cell homing receptor GPR15 in colitisCD69 is the crucial regulator of intestinal inflammation: a new target molecule for IBD treatment?Leukocyte transmigration across endothelial and extracellular matrix protein barriers in liver ischemia/reperfusion injury.Preferential recruitment of Th17 cells to cervical cancer via CCR6-CCL20 pathway.Inositol phospholipid signaling and the biology of natural killer cells.Cyclization of the urokinase receptor-derived ser-arg-ser-arg-tyr Peptide generates a potent inhibitor of trans-endothelial migration of monocytes.PKA and actin play critical roles as downstream effectors in MRP4-mediated regulation of fibroblast migration.CCL20 is elevated during obesity and differentially regulated by NF-κB subunits in pancreatic β-cells.The receptor tyrosine kinase EphB2 promotes hepatic fibrosis in mice.Identification of the Single Immunodominant Region of the Native Human CC Chemokine Receptor 6 Recognized by Mouse Monoclonal Antibodies.Low dose of propranolol down-modulates bone resorption by inhibiting inflammation and osteoclast differentiation.
P2860
Q26765191-55781243-D5BD-47A6-9679-04846347C55CQ26849785-4E49CBA6-9E3C-470E-8C04-A323569F27E1Q27011823-1A8F90E9-589A-49F1-BABD-805864D34E15Q27316832-5BB3456B-1877-4580-AE73-4F635B71B499Q27333525-AD46664F-AA33-4345-9D02-168FDEC1D770Q27335903-0319E271-68FA-43D5-9E46-CF8351355AADQ28264081-2E913482-D4F5-4E46-B71C-745B971235EBQ28275259-61E1788A-A457-4B85-BCAA-6C9782E77459Q28550697-A84B6CD0-3CC3-42FE-A519-377527A2FA18Q28595434-83456E83-EA97-41D2-81F3-696F9E42E3ABQ30009552-E902F041-057E-4AED-BD7C-A54C7615C3A4Q30366227-64C886FF-040F-4D3B-B559-7BDC0156CE97Q30537598-AD32DE3D-077E-42C0-BBB7-442B2E987D44Q33561481-04D9A561-41BD-4DFD-95E5-5C887354A551Q33574588-F04F5C89-5389-4E92-BAF3-3E0C47656300Q33754916-0950EF62-A366-4BE9-8A64-4CA83F521E40Q33869604-7905AD69-77F2-43F2-9408-225B07F4AB21Q33879279-0E9AFFF0-DC58-4635-857D-0E4C8B9F9A8FQ34026203-E63D81B1-BD7D-4630-AABB-C872FF306FBAQ34070345-8A9E4967-C904-412E-AFED-8B6E48F2AC5FQ34117570-A2576182-3E3A-4B19-89A2-6B963715CC06Q34152929-909234D6-E0E1-4CC3-8C64-DD45B63E653AQ34231807-61AFAD93-2618-4A97-BDC0-8E117DF676BAQ34290822-99EE29EC-E73D-49A6-B219-15E61F233B30Q34629980-ECA637EC-2BE0-4454-A3EA-8844AF0F9683Q34687251-741D0CF1-654E-4F94-92FF-1E9F31701DAFQ34803380-95BD6223-FE0E-4CDF-96AA-90E4DD287A90Q34981574-B98EDD05-FEAA-4FFF-BB47-45C379CE56D7Q35095152-9F39B17F-D133-4F22-95EA-34012F932922Q35114333-DFC54276-C827-40D7-80CD-DA71035F3BCFQ35155979-2F3245F2-0B68-4E8B-8DE9-A5981BD56CD4Q35167030-3C205DBE-43D5-4A7A-9864-E7D4929CF3F5Q35175783-1F9061A1-87AF-446A-9A2E-9D92270926F0Q35559739-FA5456CE-C44B-4C16-8575-2502708238EEQ35621562-32B7CE05-EF4D-4EF5-AECA-13AE52C75053Q35624969-3A013EC2-7BB5-48CC-95D2-C076C385559DQ35625034-7A33EE7F-830B-415A-8FA0-8001E6F81181Q35995449-63ADB728-C97B-4A30-B098-D42AD88E3F9AQ36059926-A5210F89-4EEB-4710-A048-FA482C26D893Q36147294-056CB836-D541-4786-BB03-BD3E1FA0FF8A
P2860
Moving targets: cell migration inhibitors as new anti-inflammatory therapies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Moving targets: cell migration inhibitors as new anti-inflammatory therapies.
@en
Moving targets: cell migration inhibitors as new anti-inflammatory therapies.
@nl
type
label
Moving targets: cell migration inhibitors as new anti-inflammatory therapies.
@en
Moving targets: cell migration inhibitors as new anti-inflammatory therapies.
@nl
prefLabel
Moving targets: cell migration inhibitors as new anti-inflammatory therapies.
@en
Moving targets: cell migration inhibitors as new anti-inflammatory therapies.
@nl
P2860
P356
P1433
P1476
Moving targets: cell migration inhibitors as new anti-inflammatory therapies.
@en
P2860
P304
P356
10.1038/NI.F.210
P407
P577
2008-09-01T00:00:00Z